Study of Erbitux (Cetuximab) in Patients With Metastatic Colorectal Carcinoma

Clinical trial NCT00044863 · COMPLETED

Trial details

NCT number: NCT00044863
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Neoplasms Metastases, Neoplasm

Start date: 2002-08-01
Primary completion: 2005-12-01
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.